-transparent.png){kind=logo}
This multicentric study compared 14-day treatment with loratadine (Clarityne) 10 mg once daily, terfenadine 60 mg twice daily and placebo in outpatients with seasonal allergic rhinitis. Of 275 patients enrolled, 256 (87 in the loratadine group, 89 in the terfenadine group and 80 in the placebo group) were evaluable for efficacy and 266 (90, 91 and 85 in respective groups) were evaluable for safety. Investigators graded the severity of 4 nasal and 4 nonnasal signs/symptoms and investigators and patients rated overall disease condition and therapeutic response on treatment days 3, 7 and 14; patients recorded when signs/symptoms of rhinitis were relieved, as well. Hematology and blood chemistry tests were conducted before and after therapy, and patients were questioned throughout the study about possible adverse experiences. At all visits, loratadine and terfenadine were significantly superior to placebo (p less than or equal to 0.004), and the two active medications were statistically comparable, based on mean totals of sign/symptom severity scores and ratings of overall disease condition and therapeutic response. By patients' last valid visit, mean totals of sign/symptoms severity scores improved by 56% and 53% for loratadine and terfenadine groups, respectively, but exacerbated by 5% for the placebo group. Moreover, an excellent or a good therapeutic response was observed in 58/87 (67%) loratadine-treated patients and 58/89 (65%) terfenadine-treated patients, as compared to 13/80 (16%) placebo-treated patients (p less than 0.01). A total of 61/76 (30%) patients in the loratadine group and 57/78 (73%) in the terfenadine group versus 22/71 (31%) in the placebo group experienced relief within the first 3 days of therapy (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
October 1989,
Annals of allergy,
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
May 1988,
The Journal of allergy and clinical immunology,
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
May 2017,
Allergy and asthma proceedings,
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
May 1990,
Allergy,
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
April 2000,
Ear, nose, & throat journal,
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
November 1996,
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
January 1992,
Clinical therapeutics,
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
May 1998,
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
April 1988,
The Journal of allergy and clinical immunology,
F Horak, and
G Bruttmann, and
P Pedrali, and
B Weeke, and
L Frølund, and
H H Wolff, and
E Christophers
January 1986,
The Journal of international medical research,
